London Daily

Focus on the big picture.
Thursday, Jul 10, 2025

COVID-19 treatment pill administered in new Pfizer clinical trial

US pharmaceutical giant Pfizer has started giving people a pill against COVID-19 as part of a new clinical trial. If the study is successful, Pfizer said it would file again for emergency approval between October and December this year, and the what Trump calls ‘kong flu’ might became just what it is: yet another coronavirus that has been part of our lives for the past 500 years.

The company's oral antiviral treatment has entered a mid-to-late-stage trial and is being tested on adults with COVID-19 symptoms who have not been treated in hospital and are not at risk of becoming severely ill.

Pfizer is one of several drug manufacturers hoping to develop the first antiviral pill to be taken for early signs of the illness.

Follow live COVID-19 updates

The study will involve 1,140 participants and will combine the treatment, PF-07321332, with a low dose of ritonavir, which has previously been used with other antiviral medications.

Patients will receive the treatment or a placebo orally every 12 hours for five days.





PF-07321332 is designed to block the activity of the main enzyme that is needed for the virus to replicate.

If the trial is successful, Pfizer said it would file for emergency approval between October and December this year.

The drug manufacturer said it could be prescribed at the first sign of infection, without requiring hospitalisation.

The company is running a separate trial involving people who are not in hospital but are at risk of becoming severely ill, which began in July.

There are no antiviral treatments for coronavirus that have been approved for use in the UK.

Gilead Sciences' remdesivir, administered intravenously, is the only approved antiviral treatment for COVID in the US.

Another COVID-19 pill, molnupiravir, by Merck and its partner Ridgeback Biotherapeutics, is already being studied in a late-stage trial in patients who are not in hospital to see if it lowers the risk of hospitalisation or death.

A separate late-stage trial is looking at whether taking molnupiravir can prevent people from being infected with COVID-19.

The prime minister, Boris Johnson, said in April that he hoped pills or capsules could be available by the autumn to help fight a possible further wave of the virus.

A government taskforce was launched to identify the most promising antiviral treatments - particularly those that can be taken at home - and support their development through clinical trials.




Comments

Oh ya 4 year ago
So they took Ivermectin and gave it another name so they can patent it and make a bunch of money.. Anything for the all mighty dollar.

Newsletter

Related Articles

0:00
0:00
Close
Severe Heatwave Claims 2,300 Lives Across Europe
NVIDIA Achieves Historic Milestone as First Company Valued at $4 Trillion
Declining Beer Consumption Signals Cultural Shift in Germany
Linda Yaccarino Steps Down as CEO of X After Two Years
US Imposes New Tariffs on Brazilian Exports Amid Political Tensions
Azerbaijan and Armenia are on the brink of a historic peace deal.
Emails Leaked: How Passenger Luggage Became a Side Income for Airport Workers
Polish MEP: “Dear Leftists - China is laughing at you, Russia is laughing, India is laughing”
BRICS Expands Membership with Indonesia and Ten New Partner Countries
Weinstein Victim’s Lawyer Says MeToo Movement Still Strong
U.S. Enacts Sweeping Tax and Spending Legislation Amid Trade Policy Shifts
Football Mourns as Diogo Jota and Brother André Silva Laid to Rest in Portugal
Labour Expected to Withdraw Support for Special Needs Funding Model
Leaked Audio Reveals Tory Aide Defending DEI Record
Elon Musk Founds a Party Following a Poll on X: "You Wanted It – You Got It!"
London Stock Exchange Faces Historic Low in Initial Public Offerings
A new online platform has emerged in the United Kingdom, specifically targeting Muslim men seeking virgin brides
Trump Celebrates Independence Day with B-2 Flyover and Signs Controversial Legislation
Boris Johnson Urges Conservatives to Ignore Farage
SNP Ordered to Update Single-Sex Space Guidance Within Days
Starmer Set to Reject Calls for Wealth Taxes
Stolen Century-Old Rolls-Royce Recovered After Hotel Theft
Macron Presses Starmer to Recognise Palestinian State
Labour Delayed Palestine Action Ban Over Riot Concerns
Swinney’s Tax Comments ‘Offensive to Scots’, Say Tories
High Street Retailers to Enforce Bans on Serial Shoplifters
Music Banned by Henry VIII to Be Performed After 500 Years
Steve Coogan Says Working Class Is Being ‘Ethnically Cleansed’
Home Office Admits Uncertainty Over Visa Overstayer Numbers
JD Vance Questions Mandelson Over Reform Party’s Rising Popularity
Macron to Receive Windsor Carriage Ride in Royal Gesture
Labour Accused of ‘Hammering’ Scots During First Year in Power
BBC Head of Music Stood Down Amid Bob Vylan Controversy
Corbyn Eyes Hard-Left Challenge to Starmer’s Leadership
London Tube Trains Suspended After Major Fire Erupts Nearby
Richard Kemp: I Felt Safer in Israel Under Attack Than in the UK
Cyclist Says Police Cited Human Rights Act for Riding No-Handed
China’s Central Bank Consults European Peers on Low-Rate Strategies
AI Raises Alarms Over Long-Term Job Security
Saudi Arabia Maintains Ties with Iran Despite Israel Conflict
Musk Battles to Protect Tesla Amid Trump Policy Threats
Air France-KLM Acquires Majority Stake in Scandinavian Airlines
UK Educators Sound Alarm on Declining Child Literacy
Shein Fined €40 Million in France Over Misleading Discounts
Brazil’s Lula Visits Kirchner During Argentina House Arrest
Trump Scores Legislative Win as House Passes Tax Reform Bill
Keir Starmer Faces Criticism After Rocky First Year in Power
DJI Launches Heavy-Duty Coaxial Quadcopter with 80 kg Lift Capacity
U.S. Senate Approves Major Legislation Dubbed the 'Big Beautiful Bill'
Largest Healthcare Fraud Takedown in U.S. History Announced by DOJ
×